Barbara Ann Karmanos Cancer Institute - Detroit Headquarters

Detroit, Michigan 48201

0 studies enrolling now · 3 studies all time

What they study most

Biochemically Recurrent Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer, Urothelial Carcinoma

Studies at this site

• A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies — Running, not enrolling
• A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study. — Running, not enrolling
• Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma — Completed